![Viruses | Free Full-Text | Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron Viruses | Free Full-Text | Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron](https://pub.mdpi-res.com/viruses/viruses-15-00530/article_deploy/html/images/viruses-15-00530-g001a.png?1676520456)
Viruses | Free Full-Text | Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron
![Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study - Furuta - 2023 - Transfusion - Wiley Online Library Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study - Furuta - 2023 - Transfusion - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9ed7ea23-8d75-4f5e-b625-9fcd14560a81/trf17382-fig-0003-m.jpg)
Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study - Furuta - 2023 - Transfusion - Wiley Online Library
Co-IP assay identified MERS-CoV NP as an Hsp90β client protein. 293T... | Download Scientific Diagram
![Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/asset/f6ce8544-e326-49cc-815e-3a4c91c5f641/gr1.jpg)
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe
![Antibodies | Free Full-Text | Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein Antibodies | Free Full-Text | Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein](https://pub.mdpi-res.com/antibodies/antibodies-13-00005/article_deploy/html/images/antibodies-13-00005-g001.png?1704458792)
Antibodies | Free Full-Text | Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein
![Frontiers | Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection Frontiers | Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection](https://www.frontiersin.org/files/Articles/721328/fimmu-12-721328-HTML-r1/image_m/fimmu-12-721328-t001.jpg)